Advanced search
Publication Cover
HIV Clinical Trials Volume 10, 2009 - Issue 5
Submit an article Journal homepage
42
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Subjective Clinical Lipoatrophy Assessment Correlates with DEXA-Measured Limb Fat

Marisa TungsiripatDepartment of Infectious DiseasesCleveland Clinic Foundation, Cleveland, Ohio, USA
,
Mary Ann O’RiordanDepartment of Pediatrics Rainbow Babies and Childrens’ Hospital, Case Western Reserve University, Cleveland, Ohio, USA
,
Norma StorerDepartment of Pediatrics Rainbow Babies and Childrens’ Hospital, Case Western Reserve University, Cleveland, Ohio, USA
,
Danielle HarrillDepartment of Pediatrics Rainbow Babies and Childrens’ Hospital, Case Western Reserve University, Cleveland, Ohio, USA
,
Jason GanzUniversity Hospitals Case Medical Center Cleveland, Ohio, USA
,
Daniel LibuttiDepartment of Medicine, Hawaii AIDS Clinical Research Program, University of Hawaii, Honolulu, Hawaii, USA
,
Mariana GerschensonDepartment of Medicine, Hawaii AIDS Clinical Research Program, University of Hawaii, Honolulu, Hawaii, USA
&
Grace A. McComseyDepartment of Pediatrics Rainbow Babies and Childrens’ Hospital, Case Western Reserve University, Cleveland, Ohio, USA;University Hospitals Case Medical Center Cleveland, Ohio, USACorrespondence[email protected]
 show all
Pages 314-319 | Published online: 06 Jan 2015

REFERENCES

  • Carr A, Samaras K, Burton S, et al. A syndrome of periph-eral lipodystrophy, hyperlipidaemia and insulin resis-tance in patients receiving HIV protease inhibitors. AIDS. 1998;12(7):F51–58.
  • Hatano H, Miller KD, Yoder CP, et al. Metabolic and anthro-pometric consequences of interruption of highly active antiretroviral therapy. AIDS. 2000;14(13):1935–1942.
  • Miller KD, Jones E, Yanovski JA, Shankar R, Feuerstein I, Falloon J. Visceral abdominal-fat accumulation asso-ciated with use of indinavir. Lancet. 1998;351(9106): 871–875.
  • Carr A, Workman C, Smith DE, et al. Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial. JAMA. 2002;288(2):207–215.
  • Dukers NH, Stolte IG, Albrecht N, Coutinho RA, de Wit JB. The impact of experiencing lipodystrophy on the sexual behaviour and well-being among HIV-infected homosexual men. AIDS. 2001;15(6):812–813.
  • Duran S, Saves M, Spire B, et al. Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy. AIDS. 2001;15(18):2441–2444.
  • McComsey GA, Ward DJ, Hessenthaler SM, et al. Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study. Clin Infect Dis. 2004;38(2):263–270.
  • Mulligan K, Tai VW, Algren H, et al. Altered fat distribution in HIV-positive men on nucleoside analog reverse tran-scriptase inhibitor therapy. J Acquir Immune Defic Syndr 2001 ;26(5):443–448.
  • Melial SA, John M, Moore CB, James IR, McKinnon EJ. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS. 2000;14(10):1309–1316.
  • Prior BM, Cureton KJ, Modlesky CM, et al. In vivo validation of whole body composition estimates from dual-energy X-ray absorptiometry. J Appl Physiol. 1997;83(2):623–630.
  • Salamone LM, Fuerst T, Visser M, et al. Measurement of fat mass using DEXA: a validation study in elderly adults. J Appl Physiol. 2000;89(1):345–352.
  • McComsey GA, Paulsen DM, Lonergan JT, et al. Improve-ments in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zido-vudine. AIDS. 2005;19(1):15–23.
  • Shikuma CM, Hu N, Milne C, et al. Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy. AIDS. 2001;15(14):1801–1809.
  • Hoy JF, Gahan ME, Carr A, et al. Changes in mitochondrial DNA in peripheral blood mononuclear cells from HIV-infected patients with lipoatrophy randomized to receive abacavir. J Infect Dis. 2004;190(4):688–692.
  • Carr A, Law M. An objective lipodystrophy severity grad-ing scale derived from the lipodystrophy case definition score. J Acquir Immune Defic Syndr 2003;33(5):571–576.
  • Podzamczer D, Ferrer E, Martinez E, Team AS. How much fat loss is needed for lipoatrophy to become clinically evident? Paper presented at: 15th Conference on Retro-viruses and Opportunistic Infections; February 3–6, 2008; Boston. MA. Abstract 941.
  • Shiramizu B, Shikuma KM, Kamemoto L, et al. Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibi-tors during pregnancy. J Acquir Immune Defic Syndr. 2003;32(4):370–374.
  • Funk E, Brissett AE, Friedman CD, Bressler FJ. HIV-associated facial lipoatrophy: establishment of a validated grading scale. Laryngoscope. 2007;117(8):1349–1353.
  • Burgess CM, Quiroga RM. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol. 2005;52(2):233–239.
  • Bacchetti P, Gripshover B, Grunfeld C, et al. Fat distribu-tion in men with HIV infection. J Acquir Immune Defic Syndr 2005;40(2):121–131.
  • Gerschenson M, Shiramizu B, LiButti DE, Shikuma CM. Mitochondrial DNA levels of peripheral blood mononuclear cells and subcutaneous adipose tissue from thigh, fat and abdomen of HIV-1 seropositive and negative individuals. Antivir Ther 2005;10(Suppl 2):M83–89.
  • McComsey GA, O'Riordan M, Setzer B, Lebrecht D, Baron E, Walker UA. Uridine supplementation in HIV lipoatrophy: pilot trial on safety and effect on mitochondrial indices. Eur J Clin Nutr 2007:1031.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.